Anne Andersson

5PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2025
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

Alexios Matikas, Bjørn Naume, Hans Wildiers

|Nov 25, 2024
Adherence to adjuvant endocrine therapy after breast cancer in Sweden - a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences.

Anna De Jong, Anna Von Wachenfeldt, Lennarth Nyström

|Jul 17, 2024
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.

Alexios Matikas, Volker Möbus, Richard Greil

|Dec 09, 2023
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.

Kenny A Rodriguez-Wallberg, Hanna Pauline Nilsson, Jonas Bergh

|Nov 30, 2022
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.

Alexios Matikas, Hemming Johansson, Per Grybäck

Pageof 1

Frequent Collaborators

3 joint publications

Alexios Matikas

2 joint publications

Antonis Valachis

2 joint publications

Theodoros Foukakis

2 joint publications

Jonas Bergh